Clinical Trial: A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Phenylketonuria (PKU)
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
Brief Summary:
The goal of this Phase 2, randomized study is to assess the safety, tolerability, and pharmacokinetics (PK) of oral JNT-517 in adolescents (12 to less than 18 years of age) with PKU. Participants will receive either JNT-517 or placebo and will be blinded to their treatment assignment. Participants will have a 4 in 5 (or 80%) chance of receiving JNT-517. The study will last for up to 63 days including a Screening period, Treatment period and Follow-up period for safety.Participants will:* Take 75 mg JNT-517 or a…
Read more